CLASS II Drug recall · Reported 6 Oct 2021 · FDA Enforcement Report

ceFAZolin in Sterile Water Sterile Syringe for Injection recalled

IntegraDose Compounding Services is recalling ceFAZolin in Sterile Water Sterile Syringe for Injection, IntegraDose Compounding, distributed in Massachusetts, Minnesota, New Hampshire. The recall was initiated on 17 Sep 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot, expiry: Lot 20210803CEF-1, exp 09/17/2021; Lot 20210805CEF-3, 09/19/2021; Lots 20210806CEF-1, 20210806CEF-2, exp 09/20/2021; Lots 20210809CEF-1, 20210809CEF-2, exp 09/23/2021; Lot 20210810CEF-1, exp 09/24/2021; Lot 20210811CEF-1, exp 09/25/2021; Lot 20210812CEF-1, exp 09/26/2021
Quantity recalled2,614 syringes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0896-2021
FDA event ID
88731
Recalling firm
IntegraDose Compounding Services, Minneapolis, MN
Classification
Class II
Status
Terminated
Recall initiated
17 Sep 2021
FDA classified
30 Sep 2021
Reported
6 Oct 2021
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Sterility

Timeline

17 Sep 2021Recall initiated by company
30 Sep 2021Classified by FDA+13 days
6 Oct 2021Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of sterility assurance.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

ceFAZolin, 2 G/20 mL in Sterile Water, 20 mL Sterile Syringe for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-7087-1

Where it was distributed

NH, MA, MN

MassachusettsMinnesotaNew Hampshire

Questions about this recall

Why was it recalled?

Lack of sterility assurance.

Which lots are affected?

Lot, expiry: Lot 20210803CEF-1, exp 09/17/2021; Lot 20210805CEF-3, 09/19/2021; Lots 20210806CEF-1, 20210806CEF-2, exp 09/20/2021; Lots 20210809CEF-1, 20210809CEF-2, exp 09/23/2021; Lot 20210810CEF-1, exp 09/24/2021; Lot 20210811CEF-1, exp 09/25/2021; Lot 20210812CEF-1, exp 09/26/2021

Where was it sold?

NH, MA, MN

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 88731

More recalls from IntegraDose Compounding Services

All 8

Other Cefazolin recalls

All 15